Current state of prostate cancer treatment and future strategies
Prostate cancer (PCa) is the most common malignancy in men. It forms heterogeneous PCa masses with lining epithelial cells that require androgen signaling, and heterogeneous PCa masses can metastasize to lymph nodes and bone, making early diagnosis and treatment critical. PCa treatments include c...
Saved in:
| Main Authors: | Yeonhee Pyo, Ki Han Kwon |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MRE Press
2024-11-01
|
| Series: | Journal of Men's Health |
| Subjects: | |
| Online Access: | https://oss.jomh.org/files/article/20230928-100/pdf/JOMH2024041401.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current biomarkers of prostate cancer
by: I. A. Aboian, et al.
Published: (2021-12-01) -
Prostate cancer screening knowledge and attitude among men over 50 at a referral Hospital in Oshana region, Namibia
by: Lonia Kashihakumwa, et al.
Published: (2025-01-01) -
Cardiovascular risks of Asian patients on androgen-receptor-targeted agents for prostate cancer: a systematic review and meta-analysis
by: Lin Kyaw, et al.
Published: (2024-12-01) -
Experiences of men undergoing prostate cancer screening at a hospital in Gauteng, South Africa
by: Boitumelo M. Komane, et al.
Published: (2024-11-01) -
Liquid Biomarkers in Prostate Cancer Diagnosis: Current Status and Emerging Prospects
by: Yutong Liu, et al.
Published: (2025-01-01)